Medifast Community

NYSE:MED Community

1 Narratives written by author
0 Comments on narratives written by author
23 Fair Values set on narratives written by author

AN

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Future Revenue Will Decline As GLP-1 Market Shift Challenges Adaptation

Key Takeaways Medifast's adaptation to GLP-1 weight loss medications and market competition may suppress revenue growth and cause prolonged margin compression. High customer acquisition costs and declining OPTAVIA coach numbers could negatively impact earnings without effective strategies for improvement.

US$15.75

FV

21.7% undervalued

-13.99%

Revenue growth p.a.

1

0

12

about 1 month ago